Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Debio-4326 by Debiopharm International for Central Precocious Puberty: Likelihood of Approval
Debio-4326 is under clinical development by Debiopharm International and currently in Phase III for Central Precocious Puberty. According to GlobalData,...